Drug Information

Drug General Information
Drug ID
D06UPS
Former ID
DIB014510
Drug Name
Rozrolimupab
Synonyms
SYM-001; Symphoglobulin-D; Recombinant human polyclonal antibodies (rhesus D), Symphogen/Biovitrum; Recombinant polyclonal antibodies (idiopathic thrombocytopenic purpura), Symphogen/Biovitrum; Symphobodies (hemolytic disease of the newborn), Symphogen/Biovitrum; Anti-RhD (trombocytopeni, anti-D-profylax), Symphogen/Biovitrum
Drug Type
Antibody
Indication Anemia [ICD9: 280-285; ICD10:D50-D64] Discontinued in Phase 2 [548490]
Company
Symphogen A/S
CAS Number
CAS 909402-77-3
Target and Pathway
Target(s) Blood group Rh(D) polypeptide Target Info [531295]
References
Ref 548490Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025976)
Ref 531295Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura. Curr Opin Mol Ther. 2010 Dec;12(6):734-40.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.